Biotechblog

Schering-Plough: Drugmaker, Heal Thyself

June 12, 2003 Comments Off Posted in: General Biotechnology

Schering-Plough: Drugmaker, Heal Thyself It has a potential blockbuster and a savvy new CEO. With federal probers and Claritin’s expired patent to deal with, it will need both

Geron's the Biotech of the Day

June 11, 2003 Comments Off Posted in: General Biotechnology

Geron’s the Biotech of the Day Geron saw its shares rise $1.72, or 25%, to $8.68 after the company said it has received a patent that could be used in stem-cell research. The process would be used, if it’s ever needed, to provide an additional level of safety for cell therapies made from human embryonic […]